2-236166252-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000306318.5(GBX2):c.709G>A(p.Ala237Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000161 in 1,613,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000306318.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBX2 | NM_001485.4 | c.709G>A | p.Ala237Thr | missense_variant | 2/2 | ENST00000306318.5 | NP_001476.2 | |
GBX2 | XM_047443907.1 | c.709G>A | p.Ala237Thr | missense_variant | 2/4 | XP_047299863.1 | ||
GBX2 | NM_001301687.2 | c.*77G>A | 3_prime_UTR_variant | 3/3 | NP_001288616.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBX2 | ENST00000306318.5 | c.709G>A | p.Ala237Thr | missense_variant | 2/2 | 1 | NM_001485.4 | ENSP00000302251 | P1 | |
GBX2 | ENST00000551105.1 | c.*77G>A | 3_prime_UTR_variant | 3/3 | 1 | ENSP00000448747 | ||||
GBX2 | ENST00000465889.1 | n.378G>A | non_coding_transcript_exon_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249688Hom.: 0 AF XY: 0.0000813 AC XY: 11AN XY: 135294
GnomAD4 exome AF: 0.000162 AC: 237AN: 1461224Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 117AN XY: 726934
GnomAD4 genome AF: 0.000145 AC: 22AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.709G>A (p.A237T) alteration is located in exon 2 (coding exon 2) of the GBX2 gene. This alteration results from a G to A substitution at nucleotide position 709, causing the alanine (A) at amino acid position 237 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at